Next Science® Xbio Technology Expands Use into the Operating Room

October 29, 2018Press Releases

Sydney, NSW and Jacksonville, FL: Next Science® is excited to announce the release of its newest product, SurgX™, available in the US market. SurgX™ is an innovative and first of its type, sterile antimicrobial surgical wound gel designed to help reduce superficial surgical site infections (SSIs) through the management and protection of the post-surgical wound … Read More

Next Science® Expands its Board to Support Continued Global Expansion

October 18, 2018Press Releases

Sydney, NSW: Next Science is excited to announce the appointment of Aileen Stockburger and Mark Compton (AM) to the Board of the company as Non-Executive Directors. Both bring a wealth of diverse international healthcare experience to the Board, as the company expands the adoption of its Xbio™ Technology and the product applications globally across wound … Read More

George Savvides Joins Next Science Board of Directors

August 1, 2018Press Releases

Next Science welcomes George Savvides to its board of directors as Independent Chairperson. Mr Savvides is currently on the board of directors of Ryman Healthcare. He serves as the Chairman of both Macquarie University Hospital and Kings Transport Group Ltd, and is the Deputy Chairman of the Australian public broadcaster, SBS. Read the Full Release

Next Science Products to be Featured in 4 Abstracts at SAWC Spring Conference

February 12, 2018Uncategorized

Next Science is excited to announce that 4 Poster Abstracts by key wound care experts have been accepted for presentation at the Spring Symposium on Advanced Wound Care. These presentations will highlight the benefits of products powered by Next Science’s patented, non-toxic Xbio™ technology to disrupt biofilm and treat chronic wounds. Read the Full Release

New Mayo Clinic Study Demonstrates Effectiveness of BlastX for Treating Chronic Wounds

February 7, 2018Press Releases

Next Science is excited to announce the results of a prospective, randomized 12-week Mayo Clinic study about the use of BlastX antimicrobial wound gel on chronic wounds to determine if disrupting chronic wound biofilm is therapeutically efficacious. The positive results are published in WOUNDS®. The study represents statistically significant findings for both reduction in wound … Read More

Next Science’s XbioTM Technology Shows Potential to Lower Catheter-Associated Urinary Tract Infection Rates

January 26, 2018Press Releases

Next Science is pleased to announce the publication of a comprehensive article about the application of its Xbio technology to help prevent the development of E. coli biofilms on urinary tract catheters, a leading cause in catheter-associated urinary tract infections. The results are published in the Journal of Medical Microbiology & Diagnosis. View Publication Read … Read More

Judith Mitchell Joins Next Science Board of Directors

November 8, 2017Press Releases

Next Science is proud to announce that Judith Mitchell has been appointed to its board of directors as Director and Chief Executive Officer. Ms. Mitchell joined Next Science in August 2017. Most recently she was President, DePuy Synthes Asia Pacific, the Orthopaedics Division of Johnson & Johnson.

Next Science Showcasing BlastX™ at Fall Wound Care Conferences

October 2, 2017Press Releases

Next Science will highlight its BlastX Antimicrobial Wound Gel at three upcoming conferences. It will exhibit at the Wild on Wounds National Wound Conference in Las Vegas, Nevada, from October 4-7. In addition to exhibiting, it will make poster presentations at SAWC Fall from October 19-22, also in Las Vegas. And Next Science will exhibit … Read More